Parainfluenza Virus Type 3 - 9 Studies Found Completed : Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children : Parainfluenza Virus 3, Human : 2010-12-02 : Biological: rHPIV3cp45 Vaccine Completed : A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants : Healthy : 2008-05-23 : Biological: MEDI-534, Cohort 1 Completed : Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children : Healthy : 2006-06-27 : Biological: MEDI-534 10:4 TCID Completed : Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age : Respiratory Viral Infections Respiratory Syncytial Virus Infections Biological: MEDI-534 Multiple Completed : Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults : Paramyxoviridae Infections Virus Diseases : 2006-08-17 : Biological: rB/HPIV3 Live atte Terminated : A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age : Healthy : 2007-07-27 : Biological: MEDI-560 MEDI-560 Completed : Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children : Paramyxoviridae Infections Virus Diseases : 2009-11-25 : Drug: rHPIV3cp45 10^5 TCID50 n Completed : Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants : Paramyxoviridae Infections Virus Diseases : 2006-03-28 : Biological: rHPIV3cp45 Placebo Completed : Study to Evaluate MEDI-534 in Healthy Adults : Respiratory Syncytial Virus Infections Parainfluenza Infections : 2005-05-26 : Drug: MEDI-534
